» Articles » PMID: 32093043

Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China

Overview
Journal J Clin Med
Specialty General Medicine
Date 2020 Feb 26
PMID 32093043
Citations 109
Authors
Affiliations
Soon will be listed here.
Abstract

We developed a computational tool to assess the risks of novel coronavirus outbreaks outside of China. We estimate the dependence of the risk of a major outbreak in a country from imported cases on key parameters such as: (i) the evolution of the cumulative number of cases in mainland China outside the closed areas; (ii) the connectivity of the destination country with China, including baseline travel frequencies, the effect of travel restrictions, and the efficacy of entry screening at destination; and (iii) the efficacy of control measures in the destination country (expressed by the local reproduction number R loc ). We found that in countries with low connectivity to China but with relatively high R loc , the most beneficial control measure to reduce the risk of outbreaks is a further reduction in their importation number either by entry screening or travel restrictions. Countries with high connectivity but low R loc benefit the most from policies that further reduce R loc . Countries in the middle should consider a combination of such policies. Risk assessments were illustrated for selected groups of countries from America, Asia, and Europe. We investigated how their risks depend on those parameters, and how the risk is increasing in time as the number of cases in China is growing.

Citing Articles

Paving initial forecasting COVID-19 spread capabilities by nonexperts: A case study.

Roth I, Yosef A Digit Health. 2024; 10:20552076241272565.

PMID: 39161344 PMC: 11331569. DOI: 10.1177/20552076241272565.


Flexible Bayesian inference on partially observed epidemics.

Wang M, Onnela J J Complex Netw. 2024; 12(2):cnae017.

PMID: 38533184 PMC: 10962317. DOI: 10.1093/comnet/cnae017.


Pathogen evolution, prevention/control strategy and clinical features of COVID-19: experiences from China.

Wei D, Xie Y, Liu X, Chen R, Zhou M, Zhang X Front Med. 2023; 17(6):1030-1046.

PMID: 38157194 DOI: 10.1007/s11684-023-1043-5.


Safety-Critical Control of Compartmental Epidemiological Models With Measurement Delays.

Molnar T, Singletary A, Orosz G, Ames A IEEE Control Syst Lett. 2023; 5(5):1537-1542.

PMID: 37974600 PMC: 8545040. DOI: 10.1109/LCSYS.2020.3040948.


A hospital demand and capacity intervention approach for COVID-19.

Van Yperen J, Campillo-Funollet E, Inkpen R, Memon A, Madzvamuse A PLoS One. 2023; 18(5):e0283350.

PMID: 37134085 PMC: 10156009. DOI: 10.1371/journal.pone.0283350.


References
1.
Backer J, Klinkenberg D, Wallinga J . Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill. 2020; 25(5). PMC: 7014672. DOI: 10.2807/1560-7917.ES.2020.25.5.2000062. View

2.
Riley S, Fraser C, Donnelly C, Ghani A, Abu-Raddad L, Hedley A . Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science. 2003; 300(5627):1961-6. DOI: 10.1126/science.1086478. View

3.
Wearing H, Rohani P, Keeling M . Appropriate models for the management of infectious diseases. PLoS Med. 2005; 2(7):e174. PMC: 1181873. DOI: 10.1371/journal.pmed.0020174. View

4.
Nishiura H, Jung S, Linton N, Kinoshita R, Yang Y, Hayashi K . The Extent of Transmission of Novel Coronavirus in Wuhan, China, 2020. J Clin Med. 2020; 9(2). PMC: 7073674. DOI: 10.3390/jcm9020330. View

5.
Shen M, Peng Z, Xiao Y, Zhang L . Modeling the Epidemic Trend of the 2019 Novel Coronavirus Outbreak in China. Innovation (Camb). 2021; 1(3):100048. PMC: 7831648. DOI: 10.1016/j.xinn.2020.100048. View